About this event

  • Date and time Fri 24 Apr 2020 from 8:30am to 4:45pm
  • Location Royal Society of Medicine
  • Organised by Surgery, Association of Coloproctology of Great Britain and Ireland, Coloproctology

At this meeting, a multidisciplinary faculty of top experts will provide state of the art lectures on current and emerging treatments for early rectal cancer.

You will learn about less aggressive treatments and stoma avoidance, with a focus on papillon radiotherapy, get updates on clinical trials, hear a patient perspective as part of the main programme, and will be able to discuss individual cases with national and international experts.

This event will educate, inform and influence professionals caring for patients with rectal cancer on the newer options available for the treatment of early tumours, taking into account patient perspectives and the provision of specialist services in the UK and abroad. Author Mark Davis will share his experience as a patient and a multidisciplinary audience will be part of panel discussions on the topics. 

Topics include:

  • To inform the audience about the current status of "Watch and Wait" strategy after (chemo) radiotherapy for early rectal cancer - both in the UK and world wide.
  • To educate multidisciplinary team members including (but not exclusively) surgeons, oncologists, cancer nurses, pathologists and radiologists about the possibility of rectal preservation and stoma avoidance when treating early rectal cancer.
  • To gain the patient perspective on this difficult area of decision making in cancer practice.
  • To understand the influence of the Bowel Screening services on downward stage migration leading to increased diagnosis of earlier rectal cancer, and hence the need for less aggressive treatments.


Join in the conversation online

Follow us on Twitter: @RoySocMed


Standard pricing available until 23 April 2020.


RSM Fellow RSM Associate RSM Trainee RSM Retired Fellow RSM Student
£100.00 £60.00 £60.00 £60.00 £30.00


Non - Member

Consultant / GP Industry Professional Trainee Student AHP / Nurse / Midwife Patient / Carer
£195.00 £195.00 £100.00 £60.00 £60.00 £45.00


24 April 2020

Registration, tea and coffee

Session one: Early rectal cancer - options to consider

Chairs: Miss Helen Chave, President, Coloproctology Section, Royal Society Medicine and Professor Jean Pierre Gerard

Welcome and introduction

Miss Helen Chave

Surgery is the standard of care

Speaker to be confirmed

When not to operate

Professor Bill Heald, Chairman, Colorectal Programme, Champalimaud Foundation, Portugal

Contact X-ray brachytherapy

Professor A Sun Myint, Professor of Oncology, University of Liverpool

Watch and wait is an option

Professor Geerard Beets, Chairman, Department of Surgery, The Netherlands Cancer Institute in Amsterdam

Panel discussion
Tea and coffee break

Session two: Early rectal cancer - options in practice

Chairs: Miss Rachel Hargest, Clinical Senior Lecturer in Colorectal Surgery, Cardiff University and Professor Simon Gollins, Consultant Surgeon, Birmingham

Is watch and wait safe?

Associate Professor Fraser Smith, Consultant Surgeon, Liverpool

TEMS is better for early tumour

Professor Chris Cunningham, Consultant Surgeon, Oxford

Salvage surgery

Mr Ian Jenkins, Consultant Surgeon, St Mark’s Hospital

Can the NHS afford ‘watch & wait’?

Dr Chris Rao, Honorary Clinical Research Fellow, Imperial College London

Dose escalation in radiotherapy

Dr Ane Appelt, Academic Fellow, Leeds Institute of Medical Research, St James's, University of Leeds and Leeds Cancer Centre

Do patients have a choice?

Mr Mark Davies, Patient and Author

Panel discussion

Trainees Session: Professor Geerard Beets

Session three: Early rectal cancer cases

Chairs: Professor Geerard Beets

MDT Case one
MDT Case two
MDT Case three
MDT Case four
MDT Case five

Session four: Clinical trials in early rectal cancer

Chair: Professor A Sun Myint


Professor Jean Pierre Gerard, Nice, France


Mr Simon Bach, Consultant Surgeon, Birmingham


Professor Simon Gollins


Professor Eric Rullier, University of Bordeaux, France

Panel discussion
Closing of remarks

Professor A Sun Myint and Miss Rachel Hargest


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom